Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Characterization of long-term effector-memory T-cell responses in patients with resected high-risk melanoma receiving a melanoma Peptide vaccine.

Journal of immunotherapy (Hagerstown, Md. : 1997) - 1 Jan 2000

Chiong Brian, Wong Raymond, Lee Peter, Delto Joan, Scotland Ronald, Lau Roy, Weber Jeffrey

Abstract excerpt

The authors determined whether long-term memory T cells could be detected in patients who received a multipeptide vaccine for high-risk resected melanoma. Five HLA-A*0201 patients received a vaccine that included the gp100(209-217) (210M) peptide with Montanide ISA 51. Peripheral blood mononuclea...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Vaccines
Share to CD8-Positive T-Lymphocytes
Share to Clinical Trials as Topic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to gp100 Melanoma Antigen

Share to Immunologic Memory

Share to Immunotherapy

Share to Interferon-gamma

Share to Mannitol

Source

Identifiers

PMID: 15314545
DOI: 10.1097/00002371-200409000-00005

Genes

CCR7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-15314545-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Characterization of long-term effector-memory T-cell responses in patients with resected high-risk melanoma receiving a melanoma Peptide vaccine.PMID 15314545Read ↗

Phenotypic and functional maturation of tumor antigen-reactive CD8+ T lymphocytes in patients undergoing multiple course peptide vaccination.Semantic proximity Read ↗

Phenotype and functional characterization of long-term gp100-specific memory CD8+ T cells in disease-free melanoma patients before and after boosting immunization.Semantic proximity Read ↗

gp100(209-2M) peptide immunization of human lymphocyte antigen-A2+ stage I-III melanoma patients induces significant increase in antigen-specific effector and long-term memory CD8+ T cells.Semantic proximity Read ↗

Analysis of a natural immune response against tumor antigens in a melanoma survivor: lessons applicable to clinical trial evaluations.Semantic proximity Read ↗

Peptide-specific CD8+ T-cell evolution in vivo: response to peptide vaccination with Melan-A/MART-1.Semantic proximity Read ↗

Immune responses to a class II helper peptide epitope in patients with stage III/IV resected melanoma.Semantic proximity Read ↗

Polyfunctional response by ImmTAC (IMCgp100) redirected CD8+ and CD4+ T cells.Semantic proximity Read ↗

Heterogeneity of CD8 T-Cell Changes in Advanced Melanomas After Initiation of ImmunotherapySemantic proximity Read ↗

PD-1 expression conditions T cell avidity within an antigen-specific repertoireSemantic proximity Read ↗

IL-7R licenses a population of epigenetically poised memory CD8 + T cells with superior antitumor efficacy that are critical for melanoma memorySemantic proximity Read ↗

Expansion and functional maturation of human tumor antigen-specific CD8+ T cells after vaccination with antigenic peptide.Semantic proximity Read ↗

Phenotype, specificity and avidity of antitumour CD8+ T cells in melanoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.